William B. Ainsworth

Author

Also Known As

, W. B. Ainsworth, William Ainsworth, William B. Ainsworth, William Barrett Ainsworth

Publications

388

Citations

H-Index

Concepts

All Affiliations

William B. Ainsworth is an author at AbbVie (United States) specializing in tumor immunity, pharmacotherapy, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	36
2	Immunology	1	1	36
3	Pharmacology	1	1	36
4	Hematology	1	1	36
5	Immunotherapy	1	1	36

William B. Ainsworth

Publications

373

Citations

H-Index

Page 1

	Year	Citations
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow Todd A. Hopkins, William B. Ainsworth, Paul A. Ellis, Molecular Cancer Research	2018	250
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodysplastic Syndrome Amer M. Zeidan, Daniel A. Pollyea, Jacqueline S. Garcia, Blood	2019	71
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia Farhad Ravandi, Asad Bashey, James M. Foran, Blood Advances Hematological MalignancyOncologyAcute Myeloid LeukemiaHematologyPharmacology	2023	36
Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study Keith W. Pratz, Courtney D. DiNardo, Dominik Selleslag, Blood	2020	16

Page 1